NCT03013439View on ClinicalTrials.gov

Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

June 4, 2017

Study Completion Date

June 4, 2017

Conditions

AnemiaDeficiency DiseasesAnemia, Iron DeficiencyHematologic DiseaseIron Metabolism Disorders

Interventions

DRUG

Iron Isomaltoside

The trial is a dose escalating trial.

Trial Locations (1)

171-0014

Ikebukuro, Tokyo

Sponsors

Lead Sponsor

Pharmacosmos A/S

All Listed Sponsors

lead

Pharmacosmos A/S

INDUSTRY